Medicalconferences invites all the attendees from all over the world to attend An international Conference on "Cancer Science & Stem cell Research ” This conference will assemble recent researches & findings, oral talks, poster presentation ,Exhibition & other issues in Cancer science from July 29 - 30th, 2019 in Diamond city Amsterdam , Netherlands. The motive of this Conference is to explore " The Advancement in the Arena of Cancer Science & Stem cell Research” which will provide an international platform for discussion of present and future challenges in various kind of its genetically and immunological diseases, disorder, symptoms & analysis regards to Cancer & stem cell research along with education and expertise meeting on oncology conferences.
Track 1: Cancer Science : Cancer Science is a broad field which covers almost every branch of cancer research and therapy. Cancer was considered as a lethal disease until a few decades ago, but now the scenario has changed thanks to advances and new treatment techniques made in this field. There are various therapies available now to treat and diagnose cancer diseases. The Targeted Cancer Therapy is one of the finest therapies available in present, in which the cancer cells are cured by targeting and inhibiting specific molecules which are responsible for tumor progression. This blocking can be done by medicine or drugs. The Cancer Case Reports shows that Stem Cell Therapy is also an effectual treatment for cancer. Cancer biomarkers generally assist in finding tumor cells and treating them. Tumor Immunology plays highly important role in verdict of new approaches for cancer therapeutics. Cancer Conferences expresses its effort to drop cancer from the world.
Track 2: Nanotechnology / Nano Medicines In Cancer Treatment :The utilization of nanotechnology in development treatment offers some electrify potential results, consisting the probability of exterminate threat tumors with unimportant mischief to sound tissue and organs, and also the utterance and transfer of ailment cells before they outline tumors. One treatment being dealt with incorporates concentrated on chemotherapy that passes on a tumor-executing authority known as tumor decay factor alpha (TNF) to developing tumors. TNF connected with a gold nanoparticle nearby Thiol-derivatized polyethene glycol (PEG-THIOL), which impersonate the TNF bearing nanoparticle from the resistant structure. This allows the nanoparticle to course via the circulatory framework without being attacked.Track 3: Cancer Therapy: Cancer can be treated by various methods. The treatment generally depends on the location, stage and grade of cancer. Bone Marrow transplantation is a type of therapy used for treating leukemia lymphoma and myeloma. In Radiation therapy, the patient is treated with highly ionized radiations, which help in distortion of the cancer cells. Chemotherapy, is an highly effective treatment process in which anti-cancer drugs are used to treat the cancer. Cancer Immunotherapy is a type of treatment in which the immune system is activated to treat the cancer. Some cancers are sensitive to hormones, and hence, by inhibiting them, the growth of cancer can be controlled. This is known as the Hormone Therapy. Metastatic cancers can be treated with Targeted therapy, in which the location of cancer can be targeted and destroyed. Many novel approaches to Cancer Therapeutics are being reveal in the cancer science and therapy field. Cancer Science and Therapy Conferences aspire to procure mastery in the field of cancer research. Track 4: Organ-Defined Cancers:Cancer has an altered nature, in association to organ specificity. All types of cancer have different characters; the basic processes that cause cancer are same in all type of cancers. Based on the cancer location in the body organ, it is known as Organ Specific Cancers. The various forms of cancers include Breast Cancer, Bone Cancers, Ovarian Cancer, Prostrate Cancer, Neck Cancer, Lung cancer, Head cancer, skin cancer, Bile duct cancer, anal cancer etc. The tumor burden progressively hinders with regular biochemical functions carried out by the host organs. Based on the various differences in the cancer cells while they grow, lead to the development of the drug that targets the particular area, which is known as Targeted Cancer Therapy. Targeted therapy will never act like Chemotherapy (affecting the parts that are not targeted). The stem cell therapy also provides different way for treating cancer. Cancer Therapy Conferences express several developing therapies for varied cancers.Track 5: Cancer Genetics Cancer is a genetic disease activated by an increase in DNA mutations and epigenetic alterations which leads to uncontrolled cell proliferation and neoplasm formation. Mutation occurs regularly in the body of human, but still can be controlled. So, it would not be possible to cause cancer with one mutation. Commonly, It takes numerous mutations in the lifetime of a human to cause cancer. This is the reason older people have cancer, as they have multiple chances for mutations. Oncogenomics deals with the characterization of cancer- associated genes. Tumor suppressor genes are the ones that manage the cell cycle process, hence they are known as the Protective cells. These genetic changes accelerate the risk of cancer. The presence of mutated genes in germ cells can be inherited to the new progeny. Track 6: Cancer Pharmacology: Pharmacology basically deals with the study of action of drug in the body. Some of the drugs showed good results in animal model, but were not effective when used in cancer patient of less tumor burden. In such cases the tumor burden is first removed by cancer surgery and then followed by chemotherapy. This is called as adjuvant therapy. In combination with chemotherapy, a heat therapy called Hyperthermia therapy can be used to control various cancer types. Electric voltage passed through tumor cells to control or stop their progression along with chemotherapy process is known as Electro chemotherapy. The use of chemotherapy for cancer treatments leads to many side effects like cardiotoxicity, nephrotoxicity, ototoxicity etc., Cancer genetics is helpful to identifying the mode of treatment for Cancer. Cancer biomarkers effectively assist and the best technology in finding tumor cells and treating them. Cancer Conferences provides a perception about the new strategies emerging in cancer therapy.Track 7: Cancer And Precision Medicine:Precision medicine is a new field in which the probability of the disease is identified and the essential precautionary measures are taken to prevent the pain of cancer. Precision medicine is dependent on the diagnostic tests like the newborn screening, prenatal testing, carrier testing and preconception testing. In the newborn screening test, the child undergoes genetic testing to find out any defects within few days of birth. The prenatal testing is generally used to checks for defects in genes before the baby birth, in the embryo stage. To detect out the carrier of mutated genes, the carrier testing is done. Molecular imaging is done to detect and prevent the cancer. Cancer metabolomics is a major field which enhances precision medicine. Cancer genetics is a related field to identifying the nature of cancer cells and therefore preventing it. Cancer science meetings portrays modern techniques of cancer therapy. Track 8: Cancer Case Reports:Cancer case report give thorough detailed information about the diagnosis, treatments, follow ups, & the demographic profile of the patient. The literature review of other patients may also be present in a report for the reference. In cancer metastasis, the case report plays an important role in treatment of the patient. The cancer pathogenesis and its all effects can be depicted in a case report. The case report is considered to be an evidence, something which is considered very personal .Statistical sampling of the cancer patients may also be available in a case report for future reference. Cancer Therapy Conferences is a platform to innovate the advancementin novel therapy for cancer. Track 9: Artificial Intelligence And Its Scope In Cancer Therapy:Artificial Intelligence in the treatment of cancer could be a break-through worldwide in the field of cancer. When cancer is identified at an early stage, treatment is more likely to be successful. But oftenly, cancers are diagnosed at a later stage or at last stage when they are much harder to treat. Identifying cancer earlier by interrogating medical and non-medical data sets using machine and deep-learning is a possible solution to prevent cancer or identify cancer at an early stage.Track 10: Novel Anti-Cancer Drugs:There are many challenges to global drug development in the recent years. Despite wide research and development in the field of oncology, the translation of research advance into medicines that significantly improve the treatment of many cancers is witnessing slow growth. What could be the challenges in anticancer drug development, and how can they be directed? Some of the major threats the pharmaceutical industry is now a days facing, includes the increase in the cost of research and development without an improvement in productivity (i.e, the number of agents approved), the longer duration of development without a corresponding decrement in development risk; and the increasingly conservative regulatory climate coupled with the increasingly challengeable reimbursement setting. Cancer Science-2019 provides a worldwide platform to share developments concerned to Anti-cancer drugs. Track 11: Cancer Stem Cell: Cancer Stem Cell speculation hypothesizes the presence of a little inhabitants of disease cells with characteristic properties taking into account protection from traditional radio-chemotherapy regiments and enlarged metastatic potential. Clinically, the forceful idea of Cancer stem cell has been emerged to connect with expanded tumour repeat, metastatic spread, and normally poor patient result over various Cancer growth subtypes. Separation of Cancer Stem Cells has been polished through use of cell surface markers, while the useful contrasts among Cancer Stem Cells and remaining tumour cells have been portrayed via expansion, separation, and constraining weakening measures.Track 12: Bio-Markers Of Cancer Stem Cells: Liver cancer is the 5th most normally identified harm and the second most incessant cause for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) act as one of the major histological subtype and it is one of the main common Cancer human tumours worldwide. Research into the molecular biology of hepato-carcinogenesis has detected several biomarkers, which could provide more information in order to better understand the biology of HCC. High number of biomarkers have been shown to have potential predictive significance and a wide fields of molecular markers have been proven to be a good diagnostic tools for HCC however it is hard to portray HCC with a biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to particular clinical and pathological features has not yet been reported in human liver tumours.Track 13: Cancer Stem Cell Treatments: Traditional treatments against tumour, chemo-and radiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are integrated with tumour formation, support, metastasis and repeat.Therefore, with the end goal to create productive medicines that can elicit a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of Cancer Stem Cells. On-going distinguishing proof of surface markers and comprehension of atomic element is matched with Cancer Stem Cell phenotype, assisted with the plan of viable medicines.Track 14: Clinical Research And Trials In Stem Cells And Cancer:Clinical preliminaries are broadly perceived for advances in Cancer treatment because of developing new medications to help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease (GvHD), a extremely typical reaction of stem cell transplants where contributor safe cells assault solid patient cells and tissues. Generating cancer immunization systems for use alongside transplant to rejuvenate the Graft-Versus- leukemia (GVL) impact and limit malady backslide.Track 15: Gynecology Cancer : .Gynecologic cancer is a type of cancer that starts in a woman's reproductive organs. Five main types of cancer affect a woman's reproductive organs are cervical, ovarian, uterine, vaginal and vulvar. As a group, they are known to as gynecologic cancer. When gynecologic cancers are found early, treatment is more easy and effective. A 6th type of gynecologic cancer is the very rare fallopian tube cancer.
The five gynecologic cancers begin in different places within a woman's pelvis, which is the area below the stomach and in b/w the hip bones. Each gynecologic cancer is unique,and not common with different signs and symptoms, different risk factors and various prevention strategies. All women are at risk for gynecologic cancers, and risk increases with the age.Track 16: Haematology Cancer:. Blood is made up of different types of cell including red blood cells for carrying oxygen, platelets to help blood clotting and white blood cells that fight against infections. They all originally come from stem cells, which generally have the potential to develop into any type of blood cell as they divide or categorized and mature. Problems in this process, commonly known as ‘differentiation’, and it is the root of all blood cancers. Different types of blood cancer depend on when and how these problems occur in human body.These problems generally lead to your body producing large numbers of immature blood cells that can’t perform their job properly. They can also ‘clog up’ the bone marrow, which prevents from other types of blood cells from doing their job too.Unfortunately, blood cancer affects a very large number of people. According to survey report after every 14 minutes, someone in the UK is told they have a blood cancer. It shows 104 people a day. Blood cancers are divided into three groups. We have collected information on some of the more common instances.Track 17: Stem Cell Biology And Advances:
Structural microorganisms have a high potential to form into a wide range of cell types, basically unbounded to recharge various cells as long as the individual is as yet alive, offering gigantic any expectation of relieving Alzheimer's infection, fixing harmed spinal lines, treating kidney, liver and lung disease and making harmed hearts entirety. Above to this point, researchers essentially worked with two sorts of undifferentiated organisms from creatures and people: embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem-like cells with various innovations. The audit will very quickly talk about the on-going advances here.Track 18: Advanced In Tissue Regeneration:Tissue Engineering is a logical field and moreover portrayed as understanding the benchmarks of tissue and its improvement by handy exchange of insufficient tissue for clinical use. Tissue building bargains about the interrogation of mix of cells, structuring, materials methodologies, hemispherical and biochemical segments to upgrade characteristic tissues. Tissue Engineering includes the utilization of Scaffolds to shape viable tissues and organs, which can be embedded, again into the benefactor, have with the utilization of many building and materials techniques along with some ecliptic elements. It is detected with in excess of one branch which applies building information and life science ideas towards the advancement of natural substitutes which can enhance physiological qualities of organ.Track 19: Umbilical Cord Stem Cells:At present, moral and logical issues encompasses both embryonic and fatal undifferentiated cells and frustrate their across the broad usage. Interestingly, foundation microorganisms recover postnatal from the umbilical line, consisting the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest origin of cells that are fit to formulate a wide range of cell types . This report will center around the umbilical rope bent on immature microorganisms and contrast those cells and grown-up in bone marrow of undifferentiated organisms.Track 20: Neurology Cancer/ Brain Tumor:A brain tumor,called as an intracranial tumor, typicall define is an abnormal mass of tissue in which cells grow and multiply and seemingly unchecked by the mechanisms which control normal cells. More than 150 different brain tumors have been documented, but the two are main groups of brain tumors are defined as primary and metastatic.Primary brain tumors includes tumors which originate from the tissues of the brain or from the brain's immediate surroundings. Primary tumors are divided as glial (consist of glial cells) or non-glial (developed on or in the structures and size of the brain, which includes nerves, blood vessels and glands) and benign or malignant.Track 21:Stem Cell Aging: Maturing tissues experienced a dynamic decrement in homeostatic and regenerative limits, which has been assigned to degenerative changes in tissue- specific microorganisms, organism specialties and fundamental signals that directed undeveloped cell action. To understand the sub-atomic pathways associated with this age-subordinate crumbling of immature microorganism capacity will be basic or neutral for growing new treatments for disease of maturing that objective the specific reasons for age-related utilitarian decay. Here we investigate key sub-atomic pathways that are generally defined as tissues and organisms age and savage.Track 22: Stem Cell Therapy:Essential microorganisms are the body's rough materials cells from which every other cell with specific limits are created. Stem cells either ended up being new undifferentiated cells called (self-restoration) or wind up particular cells (division) with a more defined limit, for example , platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the ability to make new cell types. Track 23: Recent Advances In Stem Cell:Immature microorganisms have the high potential to form into various cell types, basically unbounded to renew different cells as long as the individual is as yet alive, offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung disease and making harmed hearts entirety. Up to this point, researchers primarily worked with two types of undeveloped cells from creatures and people: Embryonic undifferentiated cells and Non-embryonic or "grown-up" useful microorganisms. On-going research makes it conceivable to change over specific grown-up cells to expect stem-like cells with different advancements. The survey will quickly talk about the on-going advances here. Track 24: Epidermal Stem Cells:The skin continually re-establishes itself for the time of grown-up life, and the hair follicle experiences an end-less cycle of development and degeneration. Underlying microorganisms dwelling in the epidermis and hair follicle guarantee the help of grown-up skin homeostasis and hair recovery, however they take part in the fix of the epidermis after wounds. Track 25: Stem Cell Renewal: In Many tissues, mammalian maturing is related with a decrease in the replicative and effective limit of physical immature microorganisms and other self-regenerating compartments. Understanding the theory of this decay is a noteworthy objective of maturing research. . Such methodologies incorporate try to shield undifferentiated organisms from age-advancing harm, to 'revive' principal microorganisms using pharmacologic specialists that moderate maturing encourage modifications in flagging, and to supplant lost undeveloped cells through regenerative drug approaches. Some progress has been made in every one of these fields in the course of the recent year and a half incorporating advances in the generation of contributor particular all-powerful undifferentiated organisms through exactly defined diplomat (iPS), gains in our knowledge of how tumour silencer flagging is controlled in self-restoring compartments to direct maturing, and further show of extracellular 'milieu' factors that affect undeveloped cell work with age.Track 26: Ethics Considerations In Stem Cell Therapy:Stem Cell Research provides incredible guarantee for understanding fundamental components of human advancement and separation, and additionally the expectation for new medications or treatment methodologies for illnesses, for instance, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In many case, human Stem Cell (hSC) inquires about additionally raises moral and political contentions. The reconstructing of useful cells to deliver start pluripotent undifferentiated organisms keeps away from the moral issues specific to embryonic foundational microorganism examine. In any hSC look into, be that as it may, problems emerge with respect to delicate downstream research, agree to give materials for hSC explore, early clinical preliminaries of hSC treatments, and oversight of hSC enquire about. These moral and strategy issues should be talked about alongside technical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic research of these issues and how they are tended to in current approaches.Track 27: Advance In Developmental Biology And Stem Cells:Developmental biology is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, metamorphic components, neurobiology, and frameworks science everyone has its heritage in stem cell science. In addition, Developmental biology keeps on moving on, maturing off more teaches, while holding its very own character. While its relative controls separate into sciences with a fixed arrangement of standards, precedents, and systems, developmental biology stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in developmental science and oncology, the developmental perspective is being reasserted as a critical research program.Track 28: Oncogenomics: It is the sub field of the genomics which is characterize with the genes related with cancer along with the main focus on the epigenetics, alterations in transcripts, genomics in cancer. Even cancer can cause genetically due to sudden compilation of the mutated genetic materials and alteration of genetic material epigenetically which outcomes in the formation of the neoplasm along with the proliferation of the uncontrolled cells. The main focus of this, is in the detection of the alternate oncogene or any tumor suppressor gene which will be helpful in the cancer diagnosis, in therapies and as well as identification of the clinical results thus may lead to increase in the treatment. There are different therapies in cancer which gave hope in the production of new product to treating cancer like Avastin, Gleevec and Herceptin.Track 29: Cancer Nutrition :Having a good, nutritious food with proper diet is very much needed and important for the people diagnosed with cancer. After having proper balanced diet, one can stay stronger for longer time. At the time of treatment for cancer like chemotherapy, it is important to maintain the weight of the body , with good strength and energy which is very useful as it decreases the risk of infection and enhance the body in healing process from the treatment of cancer. It has been noticed that cancer patients with good health have better diagnosis. And for good care of the body with proper balanced diet can be taken about the proper registered dietitian as it will help throughout the treatment process and along with the side effects as referred by the physician.Track 30: New Ideas In Cancer Treatment :mp-MRI (Multiparametric-magnetic resonance imaging) – uncovering of the twisted blood vessels is done in new prostate cancer, which is highly helpful for doctors for the treatment.FLI (Fluorescence lifetime imaging) – plays a role in the detection of cancer for breast cancer. From a single scan, physician got to know about the proteins which increasing or enhancing the growth of the cancer, thus helpful in the treatment and medication against cancer. Cryoablation (freezing) - By freezing the cancer cells or tumour cells. This will be helpful for treating against the cancer. This is also highly useful as it is not required to remove all part of the lung or organ. By with the help of focal laser ablation along with MRI, the high intensity of light from laser beam targets the cancerous cells. As if the scanned image showed the imaging of the cancer, it can be detected easily and destroyed at early stage. Treatment in which drugs are totally excluded- different kinds of therapies like yoga, medication, hypnosis, massage can be useful after any type of chemical treatments like chemotherapy or may be type of chemical radiation. Even acupuncture is useful – uses needles which fix under the skin, and useful to get relives form depression, fatigue, night sweats, pain, night sweats, change in the life styles, hot flashes. Taking good healthy diet, by avoiding fat foods, limitation or to have control in drinks is also too much useful. Even some type of working outs are useful.Track 31: Pediatric oncology :Childhood cancer also called as pediatric cancer is cancer in a child. In the United States, a subjective adopted standard of the ages used are 0–14 years including, that is, up to 14 years 11.9 months of age. However in actual, the definition of childhood cancer sometimes composed adolescents between 15–19 years old. Pediatric oncology is the branch of medicine concerned with the detection and treatment of cancer in children.Worldwide, it is evaluated that childhood cancer has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. In developed countries, childhood cancer has a mortality of approximately 20% of cases, in low resource methods; on the other hand, mortality is approximately 80%, or even 90% in the world's poorest countries. In many of the developed countries the incidence is slowly increasing, as rates of childhood cancer increased by 0.6% per year b/w 1975 and 2002 in the United States & by 1.1% per year b/w 1978 and 1997 in Europe.
MedicalConferences invites participants from across the globe to join the “International Conference on Cancer Science & Stem cell Research” going to be held during July 29-30, 2019, Amsterdam, Netherlands. The conference comprises Keynote Presentations, Oral Talks, Poster Presentations, Product Launches and Exhibitions. Cancer Science & Stem cell Research -2019 is a specially designed cluster conference, whose main theme is “The Advancement in the Arena of Cancer Science & Stem cell Research”. This highly impactful conference covers a wide spectrum of important sessions.
Cancer is the second highest leading cause of death worldwide. It’s necessary that we remember cancer is not one disease – it’s more than 200 cancer diseases involved, each of them different requiring respectively suitable approaches for their treatment. Treatments that work for some cancers do not work for others, and there are few cases where treatments simply stop working abruptly, reasons being unknown. To get rid from these problems, only a global research for answers is what is to be called for. The conference will provide exceptional opportunities for academicians from Universities and Institutes to interact with world-class Scientists, researchers and Industrial Professionals working in the field of cancer/oncology. Oncology & stem cell research 2019 will explore new ideas and advancements on a global scale in topics like Cancer Science, Nanotechnology / Nano Medicines In Cancer Treatment ,Cancer Therapy, Organ-Defined Cancers, Cancer Genetics, Cancer Pharmacology, Cancer And Precision Medicine, Cancer Case Reports, Artificial Intelligence And Its Scope In Cancer Therapy, Novel Anti-Cancer Drugs, Cancer Stem Cell, Bio-Markers Of Cancer Stem Cells, Cancer Stem Cell Treatments, Clinical Research And Trials In Stem Cells And Cancer, Bioinformatics And Systems Biology, 3D Bio Printing & Bio Fabrication,Stem Cell Biology And Advances, Advanced In Tissue Regeneration,Stem Cell And Tissue Homeostas is Advanced In Tissue Regeneration,Umbilical Cord Stem Cells ,Stem Cell And Tissue Homeostasis ,Stem Cell Aging, Stem Cell Therapy, Recent Advances In Stem Cell,Epidermal Stem Cells, Stem Cell Renewal, Ethics Considerations In Stem Cell TherapyAdvance In Developmental Biology And Stem Cells, Oncogenomics ,Cancer Nutrition, New Ideas In Cancer Treatment.
The Amsterdam Metropolitan Area is home to some of the world’s biggest museums, iconic locations and the famous 400-year-old Canal Ring. Amsterdam is a top international destination for conventions and conferences, and hosts an average of 650+ meetings per year, attracting over 700,000 business visitors. Visitors of all types have plenty to do while they are here. The city’s cultural agenda holds world-class exhibitions, theatre performances, live music and other spectacular events, and its charming neighborhoods are full of shops, cafes and restaurants. The resources given below will give an overview and helps you plan the right itinerary. Now a days, the Netherlands Cancer Institute - Anton van Leuwenhoek Hospital accommodates approximately 550 Scientists and Scientific Support Personnel, 53 Medical Specialists, 180 beds, an out-patients clinic with 30,600 visits, 6 operating theaters, and 11 Irradiation units. It is the only dedicated cancer center in the Netherlands, officially accredited as Comprehensive Cancer Center by the OECI, and holds high importance as the National and International center for scientific and clinical expertise, development and training. The Cancer Center, Amsterdam houses one of the biggest oncology research centers in the Netherlands, joining cancer researchers from the Academic Medical Center and the VU University Medical Center, Amsterdam. All researchers, clinicians, technicians, research nurses and other people who are involved in oncological research are invited to attend the conference, From the day the NKI-AVL was established, close collaboration between scientists and clinicians was seen as an needed element in fighting cancer. Having a laboratory and hospital under one roof in a single independent organization with an open and collaborative atmosphere has lead to many important discoveries and improved therapies. Market Analysis Report: In the recent years there have been advancements & innumerable therapies and the research for cancer treatments or cure has been accelerating. The current reports on the global cancer diagnostics market for the forecast period of 2015 to 2020 defines that this market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow and has to be increased at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period. The global cancer diagnostics market is beholding a rapid transformation owing to various technological advancements in the diagnostic field. BCC Research reports show the global market for next generation cancer diagnostic as $1.6 billion in 2013 which has reached $1.8 billion in 2014 and is expected to reach $10 billion in 2019, registering a compound annual growth (CAGR) of 42.6% over the 5 year period. The global cancer diagnostics market is based on technology, application, and region. Based on technology, the cancer diagnostics market is divided into Platform-based and Instrument-based. The Instrument-based segment was expected to account for a big share of the cancer diagnostics market, in 2015. Based on the application, the cancer diagnostics market is divided into Lung cancer, Breast cancer, Colorectal cancer, Melanoma, and others. Based on region, the market is categorized into North America, Europe, Asia, and Rest of the World. Rest of the World part consist Latin America, Pacific countries, and Middle East and Africa. North America is seen to reckon for the highest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is stated to grow at the highest CAGR in the coming 5 years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.
Figure 1: Cancer Diagnostic Market by Region (2015- 2020)
The global market for cancer vaccines and drugs was about $4.0 billion in 2013. This market reached about $4.2 billion in 2014 and is expected to reach $4.5 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019, while the global cancer vaccines market is approximately expected to grow at a CAGR of 12-18% over the period (2017 - 2022). Worldwide revenue for vaccine was nearly $31.8 billion in 2011. This market has increased from $33.6 billion in 2012 and is expected to increase to $43.4 billion in 2019 at a compound annual growth rate of 5.3%.
Figure 2: Cancer Vaccine Market Revenue (2014- 2019)
The global ovarian cancer drug and diagnostic market was evaluated at $16.1 billion in 2012 and $18.7 billion in 2013 and is expected to reach $34.6 billion by 2018, a compound annual growth rate of 13.1% between 2013-2018. The global market for cancer profiling reached $26.1 billion in 2012 and nearly $30.1 billion in 2013 and is expected to reach $54.8 billion in 2019, a compound annual growth rate of 12.8% over the six-year period, 2013 - 2018.